Manufactering Plants | NVAX Message Board Posts


NVAX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  193567 of 198565  at  10/2/2022 8:40:22 AM  by

BillyT


 In response to msg 193566 by  andrew0329
view thread

Re: Manufactering Plants

You obviously dont remember how much it cost Novavax to break the lease on their office space after the failed RSV trial. This is another example of Ercks poor planning. They are spending many millions building out this space. It does have manufacturing space. Right now it only handles small batch manufacturing up to 50L. They plan to expand eventually to commercial manufacturing, but that is several years away. Right now it is all process development work, which we know is difficult to scale.

The biggest issue is they cant manufacture at commercial scales (2000l and up) themselves at Praha. At least they have not been approved yet. They have spent 2 years and several hundred million $ trying to get there. Why do you think they needed to use SII for their bivalent and combo vaccines? They have not figured it out yet themselves.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 3  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
193569 Re: Manufactering Plants andrew0329 0 10/2/2022 8:59:19 AM
193572 Re: Manufactering Plants PT22 0 10/2/2022 12:38:10 PM




Financial Market Data provided by
.
Loading...